Your Medications At Our Cost- Zero Markup

INVEST IN SCRIPTCO TODAY!

ScriptCo is attempting to revolutionize healthcare by selling prescription medications at cost, ZERO markup. The company believes that they are the first and only pharmacy in America doing this. The quote tool on their website provides transparency, allowing anyone to search for any generic medicine to see the actual wholesale cost. ScriptCo is helping thousands of Americans in 48 states and DC, saving them $1,000 on average compared to people with health insurance, based on an internal phone survey.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
ScriptCo

Reasons to Invest

  • ScriptCo is a membership-based pharmacy making prescription medications more affordable for everyone by selling generic medication without any markups.


  • 58 million Americans say they can not afford their medications, and almost 66% of Americans take a prescription medication (source & source). 


  • 86% of Americans agree that Congress should focus on cracking down on abusive health insurance practices that make it harder for people to get the care they need (source). 







OVERVIEW


We’re a membership-based pharmacy dedicated to making prescription medication affordable for everyone


We started ScriptCo with one purpose in mind: to help people by offering transparency and access for all.  In order to achieve this goal, we created a mail-order pharmacy that covers all aspects of fulfillment in-house. By removing all unnecessary costs and not partnering with health insurance companies, we are able to sell generic medications at wholesale cost. The only margin we make is from our membership fees, not medications, because that’s how it should be.


The Problem & our Solution


Millions of Americans can’t afford their medications, so we’re selling them at cost


It’s a sad truth that over 58 million Americans can’t afford their medication (source). With more than 4 billion prescriptions dispensed every year in the US, it is crucial for people to have access to affordable medication (source). ScriptCo is seeking to redefine how people buy their medication by selling prescription meds at cost. Unlike most retail pharmacies, we operate outside the insurance system so we can avoid unnecessary costs like prior authorizations, formulary limitations, and day supply limitations. Membership with ScriptCo is simple, members can pay $50 for a 3-month membership or $140 for a 12-month membership. We dispense any non-controlled medication.




The Market & our traction


Tens of millions of Americans are looking for affordable alternatives to get their medication, and we can be their lifeline


ScriptCo is already helping over 2,300 paying subscribers, and we believe we are positioned to scale to address the 58 million Americans who are struggling to afford their medications. Since our 2019 launch, we have already been featured in the national spotlight. We are proud to have been featured on the cover of Consumer Reports for May of 2022 for cash pay pharmacies, and most notably, we were featured on The Today Show for disrupting the pharmacy industry. As of this campaign, we are licensed in 48 states plus DC and are working with healthcare plans and self-funded employers to build a B2B platform that will allow a plan sponsor to pay for the membership or medications on a per member, monthly basis.



*These testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.

why invest





Help usher in a more transparent, more affordable future of healthcare


The vast majority of Americans agree that the healthcare industry needs to change. About 131 million Americans take prescription drugs, almost half of that population states they cannot afford them (source). Aside from a massive target market, these are regular people who are just trying to stay healthy, and we believe they have the right to do so. With this capital raise you will help ScriptCo reach consumers through advertising and finalize our B2B platform. Help us redefine healthcare accessibility, and support millions of Americans in the process, by becoming a shareholder in ScriptCo today.



 

Bold (⌘B)

ABOUT

HEADQUARTERS
6916 Woodway Dr
Woodway, TX 76712
VALUATION
$14.62M

ScriptCo is attempting to revolutionize healthcare by selling prescription medications at cost, ZERO markup. The company believes that they are the first and only pharmacy in America doing this. The quote tool on their website provides transparency, allowing anyone to search for any generic medicine to see the actual wholesale cost. ScriptCo is helping thousands of Americans in 48 states and DC, saving them $1,000 on average compared to people with health insurance, based on an internal phone survey.

TEAM

Mark McCormick
Mark McCormick
CEO, Treasurer, Director

Mark attended Baylor University from 2002-2005. In 2005 Mark left Baylor after being selected in the first round of the MLB draft by the St. Louis Cardinals. After leaving professional baseball in 2009, Mark began his career in the healthcare space as a sales representative for Stryker Orthopedics, wherein his first year, he was a top 3 finalist for “rookie of the year” nationally. After 3+ years of growing the start-up territory, Mark’s entrepreneurial spirit led him to start his own company marketing DME and pharmaceuticals, building a start-up territory.  

In 2016 Mark and Zach Zeller co-founded three pharmacies located in Texas. Through owning and operating these pharmacies Mark has vast experience in navigating the pharmacy space and has shown exceptional abilities to grow and manage pharmacies. Mark has designed, managed, and implemented pharmacy workflow from the ground up for the 3 pharmacies in Texas that he Co-Founded in 2016. Marks leadership grew these pharmacies from start-up to $2,450,000+ in EBITDA in two years with two physical locations and one operation center. The pharmacy’s goal was to offer traditional medications as well as topically based treatment modalities while driving down patient cost giving more access to nontraditional treatment modalities that were better than the status quo. In mid-2019 Mark and Zach Zeller founded ScriptCo, the first pharmacy in America to sell medications at cost in an effort to solve this massive issue. In early 2021 Mark was added to the Forbes Next 1000 CEO’s list. https://www.forbes.com/profile/mark-mccormick/?sh=76e02964679a

Mark has been Married for 16 years and has 2 children.

Mark works 40 hours per week for ScriptCo.

Zach Zeller
Zach Zeller
President, Secretary, Director

After graduating from The University of Texas at Austin as a student-athlete competing in Track and Field, setting a school record, becoming an All American, and multiple time Big 12 champion, Zach went directly into medical device sales. Zach was in the operating room for more than nine years and was nationally recognized by two different multi-billion-dollar orthopedic companies. 

After deciding to move out of the surgical space and into the pharmacy space Zach and Mark McCormick co-founded three pharmacies located in Texas. Zach helped grow the company from start-up to $2,450,000 in EBITDA in two years with two physical locations and one operation center. The pharmacy’s goal was to offer traditional medications as well as topically based treatment modalities all while driving down patient cost giving more access to traditional and nontraditional treatment modalities that were better than the status quo. In mid-2019 Mark and Zach Zeller founded ScriptCo, the first pharmacy in America to sell medications at cost in an effort to solve this massive issue.

Zach has been married for 16 years and has 3 children.

Zach works 40 hours per week for ScriptCo.

Shailendra Gupta
Shailendra Gupta
Co-Founder & CCO

Sam has been a registered pharmacist in Texas since 2004. He is an Infusion, Accreditation, and Compliance Specialist. He has a Master’s degree in Pharmacy Administration and Outcomes Research. Sam was one of the “40 Pharmacist under 40 in Texas” recognized by the Texas Pharmacy Association at their 2005 Annual meeting for his contributions to HIV research and community practice. Sam has maintained teaching relationships with several institutions over the years, including The University of Houston, The University of Phoenix, and The University of Mumbai. Sam has founded/acquired several companies over the last decade and made several successful exits. He currently consults with several nationally and internationally recognized companies in matters specifically dealing with strategic acquisitions, compliance, and healthcare.

Sam works 2 hours per week for ScriptCo.

John Kasper

John Kasper

Director

JJ is Managing Director at Blue Collective, a Venture Capital investment firm located in Brooklyn, NY. Blue Collective has $100 MM in assets under management and invests exclusively in super early-stage startups across the industry founded by phenomenal entrepreneurs. Prior to founding Blue, JJ was a Restructuring executive and a Partner at McKinsey & Company, where he was a leader in the Private Equity practice.

John works 4 hours per month for ScriptCo.

TERMS

ScriptCo
Overview
PRICE PER SHARE
$4.25
DEADLINE
Dec 23, 2022
VALUATION
$14.62M
AMOUNT RAISED
$196,563.70
Breakdown
MIN INVESTMENT
$212.50
MAX INVESTMENT
$1,069,997.00
MIN NUMBER OF SHARES OFFERED
2,352
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
251,764

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

ScriptCo Inc.

Corporate Address

:

6916 Woodway Dr, Woodway, TX 76712

Offering Minimum

:

$9,996.00

Offering Maximum

:

$1,069,997.00

Minimum Investment Amount

(per investor)

:

$212.50











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

2,352

Maximum Number of Shares Offered

:

251,764

Price per Share

:

$4.25

Pre-Money Valuation

:

$14,620,000.00











*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

Investment Incentives & Bonuses*

Time-Based:

Friends and Family Early Birds

Invest within the first 72 hours and receive 20% bonus shares.

Super Early Bird Bonus

Invest within the first week and receive 15% bonus shares.

Early Bird Bonus

Invest within the first two weeks and receive 10% bonus shares.

Amount-Based:

$1,000+ | 5% Bonus Shares

Invest $1,000+ and receive 5% bonus shares.

$2,500+ | 10% Bonus Shares

Invest $2,500+ and receive 10% bonus shares

$5,000+ | 12% Bonus Shares

Invest $5,000+ and receive 12% bonus shares

$10,000+ | 15% Bonus Shares

Invest $10,000+ and receive 15% bonus shares

$25,000+ | 17% Bonus Shares

Invest $25,000+ and receive 17% bonus shares

$100,000+ | 20% Bonus Shares

Invest $100,000+ and receive 20% bonus shares

*All perks occur when the offering is completed.

The 10% StartEngine OWNers' Bonus

ScriptCo Inc. will offer 10% additional bonus shares for all investments committed by investors eligible for the StartEngine Crowdfunding Inc. Owner's bonus. 

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $4.25 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $425. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Inter company debt or back payments.

PRESS

Article Image
NBC2 Houston

New subscription service can help you save thousands on prescription drugs

Article Image
News3 Indianapolis

In-Depth: Prescription to Save

Article Image
Consumer Reports

Online Pharmacies Can Help You Save Big on Prescription Drugs

Article Image
The Today Show

New online pharmacy could help you save on generic medications

Article Image
News10 Rochester

Consumer Alert: Generic drugs less than the price of your co-pay? That’s the promise of a wholesale pharmacist










ALL UPDATES

11.21.22

Notice of Material Change in Offering

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the ScriptCo offering. Here's an excerpt describing the specifics of the change:


Issuer is extending campaign end date


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

11.15.22

REVIEWS FROM OUR MEMBERS!

Here is our latest reviews and a testament to what we are doing here at ScriptCo Pharmacy!

“This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.”

10.12.22

ScriptCo Pharmacy B2B contract!

ScriptCo has signed its first B2B contract with SwyftCare.  ScriptCo will be paid $10 Per Member Per Month for each SwyftCare member that signs up for a ScriptCo membership after verifying eligibility under the SwyftCare umbrella.  Our B2B platform is still in development, but we expect more contracts to come!

Here is the SwytCare website:https://swyftcare.com/

Here is a recent news release about SwytCare: https://www.digitaljournal.com/pr/swyftcare-provides-telemedicine-to-millions-of-agricultural-employees

09.29.22

ScriptCo Helps People Save Money BUT ALSO Provides EXCELLENT User Experience!

CHECK OUT OUR LATEST GOOGLE REVIEWS:

“This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.”

09.23.22

OUR FIRST B2B LETTER OF INTENT!

As promised please see our first B2B LOI that we are onboarding (as soon as our B2B portal is done).  We are really excited about the step growth that our B2B platform can bring on from a revenue and membership basis to ScriptCo Pharmacy!  Thank you PeopleOne Health!


This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success

09.21.22

ScriptCo Pharmacy Helps People and Businesses/Organizations (soon to come)!

As you are aware, we are helping consumers with their prescription drug costs with our pass-through membership model.  By purchasing a membership the member gets access to all of their non-controlled prescriptions AT COST!  

If you haven't checked out our business plan, you might be surprised to know that we will be offering a Family membership option and also a B2B platform option in the near future.

The family membership option will allow a user to signup for a family membership and add up to 3 dependents under that membership.  The family membership holder will be able to manage all medications for their family under one login.

The B2B platform will allow ScriptCo to charge a per member per month fee ($10) to their covered recipients.  With this option, an employee or member of an entity that is contracted with ScriptCo will be able to get all of their non-controlled generic medications, with no membership and no markup! We are really excited about the huge step growth this can provide.

Don't take our word for it, check out what Jeff Kimmell said.  He is the Executive Vice President of People One Health (a membership-based health care plan) and is a Pharmacist:


“This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.”

SCRIPTCO is actually awaiting an LOI from People One to service all of its members.  We will keep you updated on this relationship, but this is a really good sign of commitment for our first B2B contract without having the portal finalized!

09.15.22

Drug Pricing in America is Complicated!

No matter how you slice it, drug pricing in America is complicated and NOT TRANSPARENT.  How long has the US government promised to change drug pricing to make it cheaper and more transparent? 

At ScriptCo we are transparent and actively saving consumers money on their drug spend!  We are currently helping people in 48 states + DC!


 


09.08.22

ScriptCo is helping Floridians SAVE!

We had a news station (WPTV) out of West Palm Beach air our story!  Click the image below to check it out!


Testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success

09.02.22

$100k INVESTMENT $ REACHED!

THAT WAS QUICK!


Just 2 days ago we crossed the $50k mark and now are above the $100k mark!  Thank you for all that have invested so far and look forward to seeing where we go from here!


HOW SCRIPTCO PHARMACY HELPS PEOPLE:

If you are curious about what exactly ScriptCo Pharmacy is or how we help people, check out this News Story released in Dallas a couple of years ago.  This story explains what we do and how we help people!


OUR MEMBERS LOVE US:

Dr. Yeaman is a prescriber and a MEMBER of ScriptCo Pharmacy!  Like he said, " I've never seen anything like Scriptco in my 20 years of practice and as a patient."  Don't take his word for it, check out our other reviews on Google!

“This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.”

08.31.22

$50K INVESTMENTS REACHED!

Thank you to everyone that has invested so far, and a special thank you to our ScriptCo members that have put in their investment dollars!



REASONS TO INVEST:

Real Pharmacy and Real Cost! We are a real pharmacy built to help people, to our knowledge we are the only pharmacy in America selling prescription medications at cost with zero mark-up.

58 million Americans say they cannot afford their medications, and almost 66% of Americans take a prescription medication (source & source). Any prospective member can quote their prescriptions prior to becoming a member using our quote tool.

Our previous investment round (outside of crowdfunding) of $2.25M allowed us to invest in the infrastructure to handle up to $30M in ARR in our current leased space.

TIME IS RUNNING OUT!

In less than one week the time-based perks will be expiring.  So invest quickly to take advantage of these bonus share offers!










Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into ScriptCo.

$212.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$1,000.00

5% Bonus Shares

Invest $1,000+ and receive 5% bonus shares.

$2,500.00

10% Bonus Shares

Invest $2,500+ and receive 10% bonus shares.

$5,000.00

12% Bonus Shares

Invest $5,000+ and receive 12% bonus shares.

$10,000.00

15% Bonus Shares

Invest $10,000+ and receive 15% bonus shares.

$25,000.00

17% Bonus Shares

Invest $25,000+ and receive 17% bonus shares.

$100,000.00

20% Bonus Shares

Invest $100,000+ and receive 20% bonus shares.

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.